Tag: ViiV Healthcare

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to ViiV Healthcare

Global Antiretroviral Therapy Market Outlook to 2024, Featuring Company Profiles of Key Players ...

Added to Collection on: 2021-01-21 15:45:00

Tags for this article:

Hepatotoxins
Prevention of HIV/AIDS
Drugs
Management of HIV/AIDS
Integrase inhibitor
Protease inhibitor
Reverse-transcriptase inhibitor
ViiV Healthcare
Zidovudine
Chemical compounds
Chemical substances

Click the tags to see associated articles and topics

View Article Details
Meaningful Moment for HIV Treatment as FDA Approves ViiV's Monthly Shot

Added to Collection on: 2021-01-22 14:26:15

Tags for this article:

Chemical compounds
Hepatotoxins
Organic compounds
Prevention of HIV/AIDS
HIV/AIDS
Non-nucleoside reverse transcriptase inhibitors
Integrase inhibitors
Pyrimidines
Rilpivirine
Cabotegravir
Management of HIV/AIDS
Pre-exposure prophylaxis
ViiV Healthcare

Click the tags to see associated articles and topics

View Article Details
Antiretroviral Therapy Market Innovative Strategy by 2028 | Gilead, F. Hoffmann-La Roche, ViiV ...

Added to Collection on: 2021-02-22 05:34:55

Tags for this article:

Health sciences
Health care
Health
Business process
Prevention of HIV/AIDS
Hoffmann-La Roche
Pharmaceutical industry
Management of HIV/AIDS
Boehringer Ingelheim
Market analysis
ViiV Healthcare

Click the tags to see associated articles and topics

View Article Details
JPA Health: 2021

Added to Collection on: 2021-04-23 02:15:00

Tags for this article:

Advertising
Articles
Marketing
WE
Public relations
Social media marketing
Social media
Communication
Eli Lilly
Alkermes
Genomic Health
vitality group
Ayala Pharmaceuticals
OYSTER POINT PHARMA
SAGE Therapeutics
RHYTHM PHARMACEUTICALS
milestone pharmaceuticals
Leapfrog Group
Principia Biopharma
Merck
United States
Sanofi Genzyme
ViiV Healthcare
MERCK SHARP & DOHME
CSL Behring
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
Antiretroviral Drug Market is to Witness Significant Growth between 2021-2027 with leading ...

Added to Collection on: 2021-06-21 13:30:00

Tags for this article:

Hepatotoxins
Medical specialties
Health
Retroviridae
HIV/AIDS
Management of HIV/AIDS
Reverse-transcriptase inhibitor
Zidovudine
ViiV Healthcare
Pol
HIV
HIV and pregnancy

Click the tags to see associated articles and topics

View Article Details
GSK's ViiV signs deal to develop longer-acting HIV drugs

Added to Collection on: 2021-06-22 07:39:58

Tags for this article:

Hepatotoxins
Prevention of HIV/AIDS
Integrase inhibitors
GlaxoSmithKline
Pfizer
ViiV Healthcare
Management of HIV/AIDS
Halozyme
Reverse-transcriptase inhibitor
Medical specialties
Companies
Drugs

Click the tags to see associated articles and topics

View Article Details
GSK's ViiV Healthcare debuts first Dovato Spanish-language TV ad to help reach Latinx patients

Added to Collection on: 2021-06-28 15:22:30

Tags for this article:

Gender-neutral language
Hispanic and Latino
Latinx
Spanish grammar
Spanish language in the United States
HIV/AIDS
Intel Viiv
Articles
Medical specialties
Linguistics
ViiV Healthcare
GlaxoSmithKline

Click the tags to see associated articles and topics

View Article Details
HIV Drugs Market to Hit USD 45.58 Billion by 2028, With 5.9% CAGR; Emergence of Antiretroviral ...

Added to Collection on: 2021-06-29 09:45:00

Tags for this article:

Branches of biology
Hepatotoxins
Medical specialties
Health
Reverse-transcriptase inhibitor
Management of HIV/AIDS
HIV/AIDS
Zidovudine
ViiV Healthcare
Integrase inhibitor
HIV
Reverse transcriptase
Pune
India

Click the tags to see associated articles and topics

View Article Details
Pfizer/GSK-Backed ViiV Healthcare's HIV Drug Associated With Increased Resistance, WHO ...

Added to Collection on: 2024-03-05 18:09:23

Tags for this article:

Hepatotoxins
Integrase inhibitors
GSK plc
Pfizer
ViiV Healthcare
Dolutegravir
Cabotegravir
Abacavir/dolutegravir/lamivudine
Management of HIV/AIDS
HIV/AIDS
Pre-exposure prophylaxis
DTG

Click the tags to see associated articles and topics

View Article Details
ViiV Healthcare announces interim data at CROI indicating superior efficacy of long-acting ...

Added to Collection on: 2024-03-07 18:09:00

Tags for this article:

Integrase inhibitors
Prevention of HIV/AIDS
Non-nucleoside reverse transcriptase inhibitors
Nitriles
Pyrimidines
Rilpivirine
Treatment as prevention
Cabotegravir
ViiV Healthcare
Management of HIV/AIDS
HIV/AIDS
AIDS Clinical Trials Group
United States
HIV company

Click the tags to see associated articles and topics

View Article Details
Book a Demo